计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| M275550-5mg |
5mg |
期货 ![]() |
| |
| M275550-10mg |
10mg |
期货 ![]() |
| |
| M275550-50mg |
50mg |
期货 ![]() |
|
| 别名 | 2'-脱氧-N6-甲基腺苷3 |
|---|---|
| 英文别名 | [(2R,3S,5R)-5-[6-(methylamino)purin-9-yl]-2-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate | J-000339 | ((2R,3S,5R)-5-(6-(Methylamino)-9H-purin-9-yl)-3-(phosphonooxy)tetrahydrofuran-2-yl)methyl dihydrogen phosphate | BDBM50318029 | DTXSID701016926 |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | MRS 2179 |
| 生化机理 | 强效,选择性,竞争性P2Y 1拮抗剂(K i = 100 nM)。在体外抑制ATP诱导的谷氨酸释放,并抑制ADP引起血小板形状变化和聚集的能力。 |
| 储存温度 | -20°C储存,充氩 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 拮抗剂 |
| 作用机制 | P2Y 1 受体拮抗剂 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 纯度 | ≥98% |
| 分子类型 | 未知 |
|---|---|
| IIUPAC Name | [(2R,3S,5R)-5-[6-(methylamino)purin-9-yl]-2-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate |
| INCHI | 1S/C11H17N5O9P2/c1-12-10-9-11(14-4-13-10)16(5-15-9)8-2-6(25-27(20,21)22)7(24-8)3-23-26(17,18)19/h4-8H,2-3H2,1H3,(H,12,13,14)(H2,17,18,19)(H2,20,21,22)/t6-,7+,8+/m0/s1 |
| InChi Key | CCPLITQNIFLYQB-XLPZGREQSA-N |
| Smiles | CNC1=C2C(=NC=N1)N(C=N2)C3CC(C(O3)COP(=O)(O)O)OP(=O)(O)O |
| Isomeric SMILES | CNC1=C2C(=NC=N1)N(C=N2)[C@H]3C[C@@H]([C@H](O3)COP(=O)(O)O)OP(=O)(O)O |
| 分子量 | 425.23(free basis) |
| Reaxy-Rn | 25113683 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=25113683&ln= |
| 溶解性 | Soluble in water to 100 mM |
|---|---|
| 分子量 | 425.230 g/mol |
| XLogP3 | -2.900 |
| 氢键供体数Hydrogen Bond Donor Count | 5 |
| 氢键受体数Hydrogen Bond Acceptor Count | 13 |
| 可旋转键计数Rotatable Bond Count | 7 |
| 精确质量Exact Mass | 425.05 Da |
| 单同位素质量Monoisotopic Mass | 425.05 Da |
| 拓扑极表面积Topological Polar Surface Area | 198.000 Ų |
| 重原子数Heavy Atom Count | 27 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 617.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 3 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 预防措施声明 |
P264: 处理后要彻底洗手。 |
|---|
| 1. Nandanan E, Camaioni E, Jang SY, Kim YC, Cristalli G, Herdewijn P, Secrist 3rd JA, Tiwari KN, Mohanram A, Harden TK et al.. (1999) Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.. J Med Chem, 42 (9): (1625-38). [PMID:10229631] |
| 2. Zeng J et al.. (2014) P2Y13 receptor-mediated rapid increase in intracellular calcium induced by ADP in cultured dorsal spinal cord microglia.. Neurochem Res, 39 (11): (2240-50). [PMID:25186167] |
| 3. Wu J et al.. (2017) P2Y1R is involved in visceral hypersensitivity in rats with experimental irritable bowel syndrome.. World J Gastroenterol, 23 (34): (6339-6349). [PMID:28974901] |
| 4. Campwala H et al.. (2014) P2Y6 receptor inhibition perturbs CCL2-evoked signalling in human monocytic and peripheral blood mononuclear cells.. J Cell Sci, 127 (22): (4964-73). [PMID:25271060] |
| 5. Tianxu Liu, Mengting Zhang, Ismail Muhammad Asif, Yonglin Wu, Bin Li, Ling Wang. (2023) The regulatory effects of fucoidan and laminarin on functional dyspepsia mice induced by loperamide. Food & Function, 14 (14): (6513-6525). [PMID:37377021] [10.1039/D3FO00936J] |
| 6. Shengting Zhang, Mingrui Li, Dongbo Liu, Kunhao Qin, Yingying Xiang, Xiuling Ji, Congwen Li, Yunlin Wei. (2019) Studies on the GFP-tagged receptor or β-arrestin2 in U2OS cells reveal two separate signaling pathways of purinergic P2Y1 receptors. Analytical Methods, 11 (42): (5398-5404). [10.1039/C9AY01807G] |